Correction: What are the respiratory effects of e-cigarettes? (The BMJ (2019) 366 (15275) DOI: 10.1136/bmj.l5275);What are the respiratory effects of e-cigarettes?

The BMJ

Volumn 366, Issue , 2019, Pages

  Gotts, Jeffrey E ^a   Jordt, Sven Eric ^b,c   McConnell, Rob ^d   Tarran, Robert ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DERIVATIVE; GLYCEROL; NICOTINE; PROPYLENE GLYCOL;

AEROSOL; CHRONIC OBSTRUCTIVE LUNG DISEASE; ENDOTHELIUM; EVIDENCE BASED MEDICINE; FLAVOR; HEALTH STATUS; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IN VITRO STUDY; INNATE IMMUNITY; LUNG CANCER; LUNG TOXICITY; METHODOLOGY; NONHUMAN; POPULATION RISK; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROKARYOTE; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFLAMMATION; RESPIRATORY TRACT INJURY; REVIEW; SMOKING; SPIROMETRY; TOBACCO INDUSTRY; TOXICITY TESTING; VAPING; ADVERSE EVENT; ELECTRONIC CIGARETTE; PROCEDURES; SMOKING CESSATION; SMOKING PREVENTION;

ELECTRONIC NICOTINE DELIVERY SYSTEMS; HUMANS; SMOKING CESSATION; SMOKING PREVENTION; TOBACCO USE CESSATION DEVICES;

EID: 85072775862     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.l5980     Document Type: Erratum

References (193)

1. US Department of Health and Human Services. The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2014.
2. Ochsner A, Debakey M. Primary pulmonary malignancy: treatment by total pneumonectomy; analysis of 79 collected cases and presentation of 7 personal cases. Ochsner J 1999;1:109-25.
3. US Department of Health, Education, and Welfare. Smoking and Health: Report of the Advisory Committee to the Surgeon General of the Public Health Service. Public Health Service Publication No 1103. 1964. https://profiles.nlm.nih.gov/ps/retrieve/ResourceMetadata/NNBCXB.
4. Eaton DL, Kwan LY, Stratton K, eds. Public Health Consequences of E-Cigarettes. National Academies Press, 2018.
5. Walley SC, Wilson KM, Winickoff JP, Groner J. A Public Health Crisis: Electronic Cigarettes, Vape, and JUUL. Pediatrics 2019;143:e20182741. doi:10.1542/peds.2018-2741
6. Pisinger C, Godtfredsen N, Bender AM. A conflict of interest is strongly associated with tobacco industry-favourable results, indicating no harm of e-cigarettes. Prev Med 2019;119:124-31. doi:10.1016/j. ypmed.2018.12.011
7. Ahluwalia IB, Smith T, Arrazola RA, et al. Current Tobacco Smoking, Quit Attempts, and Knowledge About Smoking Risks Among Persons Aged ≥15 Years - Global Adult Tobacco Survey, 28 Countries, 2008-2016. MMWR Morb Mortal Wkly Rep 2018;67:1072-6. doi:10.15585/mmwr.mm6738a7
8. Wang TW, Asman K, Gentzke AS, et al. Tobacco Product Use Among Adults - United States, 2017. MMWR Morb Mortal Wkly Rep 2018;67:1225-32. doi:10.15585/mmwr.mm6744a2
9. Gottlieb MA. Regulation of E-Cigarettes in the United States and Its Role in a Youth Epidemic. Children (Basel) 2019;6:E40. doi:10.3390/children6030040
10. Patrick ME, O'Malley PM, Kloska DD, et al. Novel psychoactive substance use by US adolescents: Characteristics associated with use of synthetic cannabinoids and synthetic cathinones. Drug Alcohol Rev 2016;35:586-90. doi:10.1111/dar.12372
11. Miech R, Johnston L, O'Malley PM, Bachman JG, Patrick ME. Adolescent Vaping and Nicotine Use in 2017-2018 - U.S. National Estimates. N Engl J Med 2019;380:192-3. doi:10.1056/NEJMc1814130
12. Barrington-Trimis JL, Gibson LA, Halpern-Felsher B, et al. Type of E-Cigarette Device Used Among Adolescents and Young Adults: Findings From a Pooled Analysis of Eight Studies of 2166 Vapers. Nicotine Tob Res 2018;20:271-4. doi:10.1093/ntr/ntx069
13. Hsu G, Sun JY, Zhu SH. Evolution of Electronic Cigarette Brands From 2013-2014 to 2016-2017: Analysis of Brand Websites. J Med Internet Res 2018;20:e80. doi:10.2196/jmir.8550
14. Pearson JL, Reed DM, Villanti AC. Vapes, e-cigs, and mods: what do young adults call e-cigarettes?Nicotine Tob Res 2018. doi:10.1093/ntr/nty223
15. Galstyan E, Galimov A, Sussman S. Commentary: The Emergence of Pod Mods at Vape Shops. Eval Health Prof 2019;42:118-24. doi:10.1177/0163278718812976
16. King BA, Gammon DG, Marynak KL, Rogers T. Electronic Cigarette Sales in the United States, 2013-2017. JAMA 2018;320:1379-80. doi:10.1001/jama.2018.10488
17. Cullen KA, Ambrose BK, Gentzke AS, Apelberg BJ, Jamal A, King BA. Notes from the Field: Use of Electronic Cigarettes and Any Tobacco Product Among Middle and High School Students - United States, 2011-2018. MMWR Morb Mortal Wkly Rep 2018;67:1276-7. doi:10.15585/mmwr.mm6745a5
18. Huang J, Duan Z, Kwok J, et al. Vaping versus JUULing: how the extraordinary growth and marketing of JUUL transformed the US retail e-cigarette market. Tob Control 2019;28:146-51. doi:10.1136/tobaccocontrol-2018-054382
19. Jackler RK, Ramamurthi D. Nicotine arms race: JUUL and the high-nicotine product market. Tob Control 2019;tobaccocontrol-2018-054796. doi:10.1136/tobaccocontrol-2018-054796
20. Tsunoda S, Fukaya H, Sugihara T, Martin CJ, Hildebrandt J. Lung volume, thickness of alveolar walls, and microscopic anisotropy of expansion. Respir Physiol 1974;22:285-96. doi:10.1016/0034-5687(74)90078-4
21. Hua M, Alfi M, Talbot P. Health-related effects reported by electronic cigarette users in online forums. J Med Internet Res 2013;15:e59. doi:10.2196/jmir.2324
22. Wang MP, Ho SY, Leung LT, Lam TH. Electronic Cigarette Use and Respiratory Symptoms in Chinese Adolescents in Hong Kong. JAMA Pediatr 2016;170:89-91. doi:10.1001/jamapediatrics.2015.3024
23. McConnell R, Barrington-Trimis JL, Wang K, et al. Electronic Cigarette Use and Respiratory Symptoms in Adolescents. Am J Respir Crit Care Med 2017;195:1043-9. doi:10.1164/rccm.201604-0804OC
24. Cho JH, Paik SY. Association between Electronic Cigarette Use and Asthma among High School Students in South Korea. PLoS One 2016;11:e0151022. doi:10.1371/journal.pone.0151022
25. Schweitzer RJ, Wills TA, Tam E, Pagano I, Choi K. E-cigarette use and asthma in a multiethnic sample of adolescents. Prev Med 2017;105:226-31. doi:10.1016/j.ypmed.2017.09.023
26. Choi K, Bernat D. E-Cigarette Use Among Florida Youth With and Without Asthma. Am J Prev Med 2016;51:446-53. doi:10.1016/j. amepre.2016.03.010
27. Reid KM, Forrest JR, Porter L. Tobacco Product Use Among Youths With and Without Lifetime Asthma - Florida, 2016. MMWR Morb Mortal Wkly Rep 2018;67:599-601. doi:10.15585/mmwr. mm6721a2
28. Wills TA, Pagano I, Williams RJ, Tam EK. E-cigarette use and respiratory disorder in an adult sample. Drug Alcohol Depend 2019;194:363-70. doi:10.1016/j.drugalcdep.2018.10.004
29. Hedman L, Backman H, Stridsman C, et al. Association of Electronic Cigarette Use With Smoking Habits, Demographic Factors, and Respiratory Symptoms. JAMA Netw Open 2018;1:e180789. doi:10.1001/jamanetworkopen.2018.0789
30. Wang JB, Olgin JE, Nah G, et al. Cigarette and e-cigarette dual use and risk of cardiopulmonary symptoms in the Health eHeart Study. PLoS One 2018;13:e0198681. doi:10.1371/journal.pone.0198681
31. Centers for Disease Control and Prevention. Outbreak of Lung Injury Associated with E-Cigarette Use, or Vaping. 2019. https://www.cdc. gov/tobacco/basic-information/e-cigarettes/severe-lung-disease. html.
32. Layden JE, Ghinai I, Pray I, et al. Pulmonary Illness Related to E-Cigarette Use in Illinois and Wisconsin - Preliminary Report. N Engl J Med 2019. doi:10.1056/NEJMoa1911614
33. Centers for Disease Control and Prevention. Severe Pulmonary Disease Associated with Electronic-Cigarette-Product Use - Interim Guidance. 2019. https://www.cdc.gov/mmwr/volumes/68/wr/mm6836e2.htm?s-cid=mm6836e2-e&deliveryName=USCDC-921-DM8850.
34. Hammond D. Outbreak of pulmonary diseases linked to vaping. BMJ 2019;366:l5445. doi:10.1136/bmj.l5445
35. Itoh M, Aoshiba K, Herai Y, Nakamura H, Takemura T. Lung injury associated with electronic cigarettes inhalation diagnosed by transbronchial lung biopsy. Respirol Case Rep 2017;6:e00282. doi:10.1002/rcr2.282
36. Viswam D, Trotter S, Burge PS, Walters GI. Respiratory failure caused by lipoid pneumonia from vaping e-cigarettes. BMJ Case Rep 2018;2018:bcr-2018-224350. doi:10.1136/bcr-2018-224350
37. Cibella F, Campagna D, Caponnetto P, et al. Lung function and respiratory symptoms in a randomized smoking cessation trial of electronic cigarettes. Clin Sci (Lond) 2016;130:1929-37. doi:10.1042/CS20160268
38. Polosa R, Morjaria JB, Caponnetto P, et al. Persisting long term benefits of smoking abstinence and reduction in asthmatic smokers who have switched to electronic cigarettes. Discov Med 2016;21:99-108.
39. Veldheer S, Yingst J, Midya V, et al. Pulmonary and other health effects of electronic cigarette use among adult smokers participating in a randomized controlled smoking reduction trial. Addict Behav 2019;91:95-101. doi:10.1016/j.addbeh.2018.10.041
40. Hajek P, Phillips-Waller A, Przulj D, et al. A Randomized Trial of E-Cigarettes versus Nicotine-Replacement Therapy. N Engl J Med 2019;380:629-37. doi:10.1056/NEJMoa1808779
41. Walele T, Bush J, Koch A, Savioz R, Martin C, O'Connell G. Evaluation of the safety profile of an electronic vapour product used for two years by smokers in a real-life setting. Regul Toxicol Pharmacol 2018;92:226-38. doi:10.1016/j.yrtph.2017.12.010
42. D'Ruiz CD, O'Connell G, Graff DW, Yan XS. Measurement of cardiovascular and pulmonary function endpoints and other physiological effects following partial or complete substitution of cigarettes with electronic cigarettes in adult smokers. Regul Toxicol Pharmacol 2017;87:36-53. doi:10.1016/j.yrtph.2017.05.002
43. Cravo AS, Bush J, Sharma G, et al. A randomised, parallel group study to evaluate the safety profile of an electronic vapour product over 12 weeks. Regul Toxicol Pharmacol 2016;81(Suppl 1):S1-14. doi:10.1016/j.yrtph.2016.10.003
44. Vardavas CI, Anagnostopoulos N, Kougias M, Evangelopoulou V, Connolly GN, Behrakis PK. Short-term pulmonary effects of using an electronic cigarette: impact on respiratory flow resistance, impedance, and exhaled nitric oxide. Chest 2012;141:1400-6. doi:10.1378/chest.11-2443
45. Flouris AD, Chorti MS, Poulianiti KP, et al. Acute impact of active and passive electronic cigarette smoking on serum cotinine and lung function. Inhal Toxicol 2013;25:91-101. doi:10.3109/08958378.2 012.758197
46. Staudt MR, Salit J, Kaner RJ, Hollmann C, Crystal RG. Altered lung biology of healthy never smokers following acute inhalation of E-cigarettes. Respir Res 2018;19:78. doi:10.1186/s12931-018-0778-z
47. Ferrari M, Zanasi A, Nardi E, et al. Short-term effects of a nicotine-free e-cigarette compared to a traditional cigarette in smokers and nonsmokers. BMC Pulm Med 2015;15:120. doi:10.1186/s12890-015-0106-z
48. Boulay ME, Henry C, Bosse Y, Boulet LP, Morissette MC. Acute effects of nicotine-free and flavour-free electronic cigarette use on lung functions in healthy and asthmatic individuals. Respir Res 2017;18:33. doi:10.1186/s12931-017-0518-9
49. Lappas AS, Tzortzi AS, Konstantinidi EM, et al. Short-term respiratory effects of e-cigarettes in healthy individuals and smokers with asthma. Respirology 2018;23:291-7. doi:10.1111/resp.13180
50. Meo SA, Ansary MA, Barayan FR, et al. Electronic Cigarettes: Impact on Lung Function and Fractional Exhaled Nitric Oxide Among Healthy Adults. Am J Mens Health 2019;13:1557988318806073. doi:10.1177/1557988318806073
51. Aurora P, Stanojevic S, Wade A, et al, London Cystic Fibrosis Collaboration. Lung clearance index at 4 years predicts subsequent lung function in children with cystic fibrosis. Am J Respir Crit Care Med 2011;183:752-8. doi:10.1164/rccm.200911-1646OC
52. Woodruff PG, Barr RG, Bleecker E, et al, SPIROMICS Research Group. Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function. N Engl J Med 2016;374:1811-21. doi:10.1056/NEJMoa1505971
53. Coxson HO, Leipsic J, Parraga G, Sin DD. Using pulmonary imaging to move chronic obstructive pulmonary disease beyond FEV1. Am J Respir Crit Care Med 2014;190:135-44. doi:10.1164/rccm.201402-0256PP
54. Matthay MA, Ware LB, Zimmerman GA. The acute respiratory distress syndrome. J Clin Invest 2012;122:2731-40. doi:10.1172/JCI60331
55. Ghosh A, Coakley RC, Mascenik T, et al. Chronic E-Cigarette Exposure Alters the Human Bronchial Epithelial Proteome. Am J Respir Crit Care Med 2018;198:67-76. doi:10.1164/rccm.201710-2033OC
56. Carter T, Tucker D, Kilic A, Papadimos TJ, Barlow A, Berry E. Life-threatening Vesicular Bronchial Injury Requiring Venovenous Extracorporeal Membrane Oxygenation Rescue in an Electronic Nicotine Delivery System User. Clin Pract Cases Emerg Med 2017;1:212-7. doi:10.5811/cpcem.2017.3.33171
57. Reidel B, Radicioni G, Clapp PW, et al. E-Cigarette Use Causes a Unique Innate Immune Response in the Lung, Involving Increased Neutrophilic Activation and Altered Mucin Secretion. Am J Respir Crit Care Med 2018;197:492-501. doi:10.1164/rccm.201708-1590OC
58. Anderson WH, Coakley RD, Button B, et al. The Relationship of Mucus Concentration (Hydration) to Mucus Osmotic Pressure and Transport in Chronic Bronchitis. Am J Respir Crit Care Med 2015;192:182-90. doi:10.1164/rccm.201412-2230OC
59. Kesimer M, Ford AA, Ceppe A, et al. Airway Mucin Concentration as a Marker of Chronic Bronchitis. N Engl J Med 2017;377:911-22. doi:10.1056/NEJMoa1701632
60. Malerba M, Radaeli A, Olivini A, et al. Exhaled nitric oxide as a biomarker in COPD and related comorbidities. Biomed Res Int 2014;2014:271918. doi:10.1155/2014/271918
61. Marini S, Buonanno G, Stabile L, Ficco G. Short-term effects of electronic and tobacco cigarettes on exhaled nitric oxide. Toxicol Appl Pharmacol 2014;278:9-15. doi:10.1016/j.taap.2014.04.004
62. Muley T, Wiebel M, Schulz V, Ebert W. Elastinolytic activity of alveolar macrophages in smoking-associated pulmonary emphysema. Clin Investig 1994;72:269-76. doi:10.1007/BF00180039
63. Harris JO, Olsen GN, Castle JR, Maloney AS. Comparison of proteolytic enzyme activity in pulmonary alveolar macrophages and blood leukocytes in smokers and nonsmokers. Am Rev Respir Dis 1975;111:579-86.
64. Takahashi H, Ishidoh K, Muno D, et al. Cathepsin L activity is increased in alveolar macrophages and bronchoalveolar lavage fluid of smokers. Am Rev Respir Dis 1993;147:1562-8. doi:10.1164/ajrccm/147.6-Pt-1.1562
65. Weitz JI, Crowley KA, Landman SL, Lipman BI, Yu J. Increased neutrophil elastase activity in cigarette smokers. Ann Intern Med 1987;107:680-2. doi:10.7326/0003-4819-107-5-680
66. Shapiro SD, Goldstein NM, Houghton AM, Kobayashi DK, Kelley D, Belaaouaj A. Neutrophil elastase contributes to cigarette smokeinduced emphysema in mice. Am J Pathol 2003;163:2329-35. doi:10.1016/S0002-9440(10)63589-4
67. Churg A, Cosio M, Wright JL. Mechanisms of cigarette smoke-induced COPD: insights from animal models. Am J Physiol Lung Cell Mol Physiol 2008;294:L612-31. doi:10.1152/ajplung.00390.2007
68. Antunes MA, Rocco PR. Elastase-induced pulmonary emphysema: insights from experimental models. An Acad Bras Cienc 2011;83:1385-96. doi:10.1590/S0001-37652011005000039
69. Sohal SS, Reid D, Soltani A, et al. Reticular basement membrane fragmentation and potential epithelial mesenchymal transition is exaggerated in the airways of smokers with chronic obstructive pulmonary disease. Respirology 2010;15:930-8. doi:10.1111/j.1440-1843.2010.01808.x
70. Crystal RG. Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy. J Clin Invest 1990;85:1343-52. doi:10.1172/JCI114578
71. Stick SM, Brennan S, Murray C, et al, Australian Respiratory Early Surveillance Team for Cystic Fibrosis (AREST CF). Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening. J Pediatr 2009;155:623-8.e1. doi:10.1016/j. jpeds.2009.05.005
72. Mason SD, Joyce JA. Proteolytic networks in cancer. Trends Cell Biol 2011;21:228-37. doi:10.1016/j.tcb.2010.12.002
73. Chaumont M, van de Borne P, Bernard A, et al. Fourth generation e-cigarette vaping induces transient lung inflammation and gas exchange disturbances: results from two randomized clinical trials. Am J Physiol Lung Cell Mol Physiol 2019;316:L705-19. doi:10.1152/ajplung.00492.2018
74. Moazed F, Burnham EL, Vandivier RW, et al. Cigarette smokers have exaggerated alveolar barrier disruption in response to lipopolysaccharide inhalation. Thorax 2016;71:1130-6. doi:10.1136/thoraxjnl-2015-207886
75. Moazed F, Calfee CS. Environmental risk factors for acute respiratory distress syndrome. Clin Chest Med 2014;35:625-37. doi:10.1016/j. ccm.2014.08.003
76. Viswam D, Trotter S, Burge PS, Walters GI. Respiratory failure caused by lipoid pneumonia from vaping e-cigarettes. BMJ Case Rep 2018;2018:bcr-2018-224350. doi:10.1136/bcr-2018-224350
77. Thota D, Latham E. Case report of electronic cigarettes possibly associated with eosinophilic pneumonitis in a previously healthy active-duty sailor. J Emerg Med 2014;47:15-7. doi:10.1016/j. jemermed.2013.09.034
78. Agustin M, Yamamoto M, Cabrera F, Eusebio R. Diffuse Alveolar Hemorrhage Induced by Vaping. Case Rep Pulmonol 2018;2018:9724530. doi:10.1155/2018/9724530
79. Khan MS, Khateeb F, Akhtar J, et al. Organizing pneumonia related to electronic cigarette use: A case report and review of literature. Clin Respir J 2018;12:1295-9. doi:10.1111/crj.12775
80. Flower M, Nandakumar L, Singh M, Wyld D, Windsor M, Fielding D. Respiratory bronchiolitis-associated interstitial lung disease secondary to electronic nicotine delivery system use confirmed with open lung biopsy. Respirol Case Rep 2017;5:e00230. doi:10.1002/rcr2.230
81. Sommerfeld CG, Weiner DJ, Nowalk A, Larkin A. Hypersensitivity Pneumonitis and Acute Respiratory Distress Syndrome From E-Cigarette Use. Pediatrics 2018;141:e20163927. doi:10.1542/peds.2016-3927
82. Dicpinigaitis PV, Lee Chang A, Dicpinigaitis AJ, Negassa A. Effect of e-Cigarette Use on Cough Reflex Sensitivity. Chest 2016;149:161-5. doi:10.1378/chest.15-0817
83. Carson JL, Zhou L, Brighton L, et al. Temporal structure/function variation in cultured differentiated human nasal epithelium associated with acute single exposure to tobacco smoke or E-cigarette vapor. Inhal Toxicol 2017;29:137-44. doi:10.1080/0895 8378.2017.1318985
84. Martin EM, Clapp PW, Rebuli ME, et al. E-cigarette use results in suppression of immune and inflammatory-response genes in nasal epithelial cells similar to cigarette smoke. Am J Physiol Lung Cell Mol Physiol 2016;311:L135-44. doi:10.1152/ajplung.00170.2016
85. Law SM, Gray RD. Neutrophil extracellular traps and the dysfunctional innate immune response of cystic fibrosis lung disease: a review. J Inflamm (Lond) 2017;14:29. doi:10.1186/s12950-017-0176-1
86. Clapp PW, Pawlak EA, Lackey JT, et al. Flavored e-cigarette liquids and cinnamaldehyde impair respiratory innate immune cell function. Am J Physiol Lung Cell Mol Physiol 2017;313:L278-92. doi:10.1152/ajplung.00452.2016
87. Proctor RN. The history of the discovery of the cigarettelung cancer link: evidentiary traditions, corporate denial, global toll. Tob Control 2012;21:87-91. doi:10.1136/tobaccocontrol-2011-050338
88. Lorenz E, Stewart HL, Daniel JH, et al. The effects of breathing tobacco smoke on strain A mice. Cancer Res 1943;3:123.
89. Wynder EL, Graham EA, Croninger AB. Experimental production of carcinoma with cigarette tar. Cancer Res 1953;13:855-64.
90. Larcombe AN, Janka MA, Mullins BJ, Berry LJ, Bredin A, Franklin PJ. The effects of electronic cigarette aerosol exposure on inflammation and lung function in mice. Am J Physiol Lung Cell Mol Physiol 2017;313:L67-79. doi:10.1152/ajplung.00203.2016
91. Lee HW, Park SH, Weng MW, et al. E-cigarette smoke damages DNA and reduces repair activity in mouse lung, heart, and bladder as well as in human lung and bladder cells. Proc Natl Acad Sci U S A 2018;115:E1560-9. doi:10.1073/pnas.1718185115
92. Khosravi M, Lin RL, Lee LY. Inhalation of electronic cigarette aerosol induces reflex bronchoconstriction by activation of vagal bronchopulmonary C-fibers. Am J Physiol Lung Cell Mol Physiol 2018;315:L467-75. doi:10.1152/ajplung.00137.2018
93. Lim HB, Kim SH. Inhallation of e-Cigarette Cartridge Solution Aggravates Allergen-induced Airway Inflammation and Hyperresponsiveness in Mice. Toxicol Res 2014;30:13-8. doi:10.5487/TR.2014.30.1.013
94. Werley MS, Kirkpatrick DJ, Oldham MJ, et al. Toxicological assessment of a prototype e-cigaret device and three flavor formulations: a 90-day inhalation study in rats. Inhal Toxicol 2016;28:22-38. doi:10.31 09/08958378.2015.1130758
95. Gotts JE, Matthay MA. Sepsis: pathophysiology and clinical management. BMJ 2016;353:i1585. doi:10.1136/bmj.i1585
96. Garcia-Arcos I, Geraghty P, Baumlin N, et al. Chronic electronic cigarette exposure in mice induces features of COPD in a nicotinedependent manner. Thorax 2016;71:1119-29. doi:10.1136/thoraxjnl-2015-208039
97. Sussan TE, Gajghate S, Thimmulappa RK, et al. Exposure to electronic cigarettes impairs pulmonary anti-bacterial and anti-viral defenses in a mouse model. PLoS One 2015;10:e0116861. doi:10.1371/journal.pone.0116861
98. Miyashita L, Suri R, Dearing E, et al. E-cigarette vapour enhances pneumococcal adherence to airway epithelial cells. Eur Respir J 2018;51:1701592. doi:10.1183/13993003.01592-2017
99. Hwang JH, Lyes M, Sladewski K, et al. Electronic cigarette inhalation alters innate immunity and airway cytokines while increasing the virulence of colonizing bacteria. J Mol Med (Berl) 2016;94:667-79. doi:10.1007/s00109-016-1378-3
100. Webster MJ, Tarran R. Slippery When Wet: Airway Surface Liquid Homeostasis and Mucus Hydration. Curr Top Membr 2018;81:293-335. doi:10.1016/bs.ctm.2018.08.004
101. Ghosh A, Boucher RC, Tarran R. Airway hydration and COPD. Cell Mol Life Sci 2015;72:3637-52. doi:10.1007/s00018-015-1946-7
102. Shivalingappa PC, Hole R, Westphal CV, Vij N. Airway Exposure to E-Cigarette Vapors Impairs Autophagy and Induces Aggresome Formation. Antioxid Redox Signal 2016;24:186-204. doi:10.1089/ars.2015.6367
103. Lee KM, Hoeng J, Harbo S, et al. Biological changes in C57BL/6 mice following 3 weeks of inhalation exposure to cigarette smoke or e-vapor aerosols. Inhal Toxicol 2018;30:553-67. doi:10.1080/0895 8378.2019.1576807
104. Glynos C, Bibli SI, Katsaounou P, et al. Comparison of the effects of e-cigarette vapor with cigarette smoke on lung function and inflammation in mice. Am J Physiol Lung Cell Mol Physiol 2018;315:L662-72. doi:10.1152/ajplung.00389.2017
105. Phillips B, Titz B, Kogel U, et al. Toxicity of the main electronic cigarette components, propylene glycol, glycerin, and nicotine, in Sprague-Dawley rats in a 90-day OECD inhalation study complemented by molecular endpoints. Food Chem Toxicol 2017;109:315-32. doi:10.1016/j.fct.2017.09.001
106. Reinikovaite V, Rodriguez IE, Karoor V, et al. The effects of electronic cigarette vapour on the lung: direct comparison to tobacco smoke. Eur Respir J 2018;51:1701661. doi:10.1183/13993003.01661-2017
107. Crotty Alexander LE, Drummond CA, Hepokoski M, et al. Chronic inhalation of e-cigarette vapor containing nicotine disrupts airway barrier function and induces systemic inflammation and multiorgan fibrosis in mice. Am J Physiol Regul Integr Comp Physiol 2018;314:R834-47. doi:10.1152/ajpregu.00270.2017
108. Kozlowski LT, Whetzel CA, Stellman SD, O'Connor RJ. Ignoring puff counts: another shortcoming of the Federal Trade Commission cigarette testing programme. Tob Control 2008;17(Suppl 1):i6-9. doi:10.1136/tc.2007.020602
109. Dalhamn T. In vivo and in vitro ciliotoxic effects of tobacco smoke. Arch Environ Health 1970;21:633-4. doi:10.1080/00039896.1970.10667307
110. Kaminski EJ, Fancher OE, Calandra JC. In vivo studies of the ciliastatic effects of tobacco smoke. Absorption of ciliastatic components by wet surfaces. Arch Environ Health 1968;16:188-93. doi:10.1080/00 039896.1968.10665042
111. Pettersson B, Curvall M, Enzell CR. Effects of tobacco smoke compounds on the ciliary activity of the embryo chicken trachea in vitro. Toxicology 1982;23:41-55. doi:10.1016/0300-483X(82)90040-3
112. Agius AM, Smallman LA, Pahor AL. Age, smoking and nasal ciliary beat frequency. Clin Otolaryngol Allied Sci 1998;23:227-30. doi:10.1046/j.1365-2273.1998.00141.x
113. Lin VY, Fain MD, Jackson PL, et al. Vaporized E-Cigarette Liquids Induce Ion Transport Dysfunction in Airway Epithelia. Am J Respir Cell Mol Biol 2019;61:162-73. doi:10.1165/rcmb.2017-0432OC
114. Chung S, Baumlin N, Dennis JS, et al. Electronic Cigarette Vapor with Nicotine Causes Airway Mucociliary Dysfunction Preferentially via TRPA1 Receptors. Am J Respir Crit Care Med 2019. doi:10.1164/rccm.201811-2087OC
115. Clapp PW, Lavrich KS, van Heusden CA, Lazarowski ER, Carson JL, Jaspers I. Cinnamaldehyde in flavored e-cigarette liquids temporarily suppresses bronchial epithelial cell ciliary motility by dysregulation of mitochondrial function. Am J Physiol Lung Cell Mol Physiol 2019;316:L470-86. doi:10.1152/ajplung.00304.2018
116. Scott A, Lugg ST, Aldridge K, et al. Pro-inflammatory effects of e-cigarette vapour condensate on human alveolar macrophages. Thorax 2018;73:1161-9. doi:10.1136/thoraxjnl-2018-211663
117. Sassano MF, Davis ES, Keating JE, et al. Evaluation of e-liquid toxicity using an open-source high-throughput screening assay. PLoS Biol 2018;16:e2003904. doi:10.1371/journal.pbio.2003904
118. Higham A, Rattray NJ, Dewhurst JA, et al. Electronic cigarette exposure triggers neutrophil inflammatory responses. Respir Res 2016;17:56. doi:10.1186/s12931-016-0368-x
119. Schweitzer KS, Chen SX, Law S, et al. Endothelial disruptive proinflammatory effects of nicotine and e-cigarette vapor exposures. Am J Physiol Lung Cell Mol Physiol 2015;309:L175-87. doi:10.1152/ajplung.00411.2014
120. Higham A, Bostock D, Booth G, Dungwa JV, Singh D. The effect of electronic cigarette and tobacco smoke exposure on COPD bronchial epithelial cell inflammatory responses. Int J Chron Obstruct Pulmon Dis 2018;13:989-1000. doi:10.2147/COPD.S157728
121. Moses E, Wang T, Corbett S, et al. Molecular Impact of Electronic Cigarette Aerosol Exposure in Human Bronchial Epithelium. Toxicol Sci 2017;155:248-57. doi:10.1093/toxsci/kfw198
122. Haswell LE, Baxter A, Banerjee A, et al. Reduced biological effect of e-cigarette aerosol compared to cigarette smoke evaluated in vitro using normalized nicotine dose and RNA-seq-based toxicogenomics. Sci Rep 2017;7:888. doi:10.1038/s41598-017-00852-y
123. Rayner RE, Makena P, Prasad GL, Cormet-Boyaka E. Cigarette and ENDS preparations differentially regulate ion channels and mucociliary clearance in primary normal human bronchial 3D cultures. Am J Physiol Lung Cell Mol Physiol 2019;317:L295-302. doi:10.1152/ajplung.00096.2019
124. Clunes LA, Davies CM, Coakley RD, et al. Cigarette smoke exposure induces CFTR internalization and insolubility, leading to airway surface liquid dehydration. FASEB J 2012;26:533-45. doi:10.1096/fj.11-192377
125. Patel W, Moore PJ, Sassano MF, et al. Increases in cytosolic Ca2+ induce dynamin- and calcineurin-dependent internalisation of CFTR. Cell Mol Life Sci 2019;76:977-94. doi:10.1007/s00018-018-2989-3
126. Rasmussen JE, Sheridan JT, Polk W, Davies CM, Tarran R. Cigarette smoke-induced Ca2+ release leads to cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction. J Biol Chem 2014;289:7671-81. doi:10.1074/jbc.M113.545137
127. Einarsson GG, Comer DM, McIlreavey L, et al. Community dynamics and the lower airway microbiota in stable chronic obstructive pulmonary disease, smokers and healthy non-smokers. Thorax 2016;71:795-803. doi:10.1136/thoraxjnl-2015-207235
128. Fodor AA, Klem ER, Gilpin DF, et al. The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations. PLoS One 2012;7:e45001. doi:10.1371/journal.pone.0045001
129. Yaucher NE, Fish JT, Smith HW, Wells JA. Propylene glycolassociated renal toxicity from lorazepam infusion. Pharmacotherapy 2003;23:1094-9. doi:10.1592/phco.23.10.1094.32762
130. Blake DA, Whikehart DR, Yu H, Vogel T, Roberts DD. Common cryopreservation media deplete corneal endothelial cell plasma membrane Na+,K+ ATPase activity. Curr Eye Res 1996;15:263-71. doi:10.3109/02713689609007620
131. Morshed KM, Jain SK, McMartin KE. Acute toxicity of propylene glycol: an assessment using cultured proximal tubule cells of human origin. Fundam Appl Toxicol 1994;23:38-43. doi:10.1006/faat.1994.1076
132. Wieslander G, Norback D, Lindgren T. Experimental exposure to propylene glycol mist in aviation emergency training: acute ocular and respiratory effects. Occup Environ Med 2001;58:649-55. doi:10.1136/oem.58.10.649
133. Dalton P, Soreth B, Maute C, Novaleski C, Banton M. Lack of respiratory and ocular effects following acute propylene glycol exposure in healthy humans. Inhal Toxicol 2018;30:124-32. doi:10. 1080/08958378.2018.1470207
134. Bessac BF, Jordt SE. Breathtaking TRP channels: TRPA1 and TRPV1 in airway chemosensation and reflex control. Physiology (Bethesda) 2008;23:360-70. doi:10.1152/physiol.00026.2008
135. Niedermirtl F, Eberhardt M, Namer B, et al. Etomidate and propylene glycol activate nociceptive TRP ion channels. Mol Pain 2018;14:1744806918811699. doi:10.1177/1744806918811699
136. Caceres AI, Brackmann M, Elia MD, et al. A sensory neuronal ion channel essential for airway inflammation and hyperreactivity in asthma. Proc Natl Acad Sci U S A 2009;106:9099-104. doi:10.1073/pnas.0900591106
137. Verkman AS. Aquaporins in clinical medicine. Annu Rev Med 2012;63:303-16. doi:10.1146/annurev-med-043010-193843
138. Kreda SM, Gynn MC, Fenstermacher DA, Boucher RC, Gabriel SE. Expression and localization of epithelial aquaporins in the adult human lung. Am J Respir Cell Mol Biol 2001;24:224-34. doi:10.1165/ajrcmb.24.3.4367
139. Madeira A, Moura TF, Soveral G. Aquaglyceroporins: implications in adipose biology and obesity. Cell Mol Life Sci 2015;72:759-71. doi:10.1007/s00018-014-1773-2
140. Pocivavsek L, Gavrilov K, Cao KD, et al. Glycerol-induced membrane stiffening: the role of viscous fluid adlayers. Biophys J 2011;101:118-27. doi:10.1016/j.bpj.2011.05.036
141. Zia S, Ndoye A, Nguyen VT, Grando SA. Nicotine enhances expression of the alpha 3, alpha 4, alpha 5, and alpha 7 nicotinic receptors modulating calcium metabolism and regulating adhesion and motility of respiratory epithelial cells. Res Commun Mol Pathol Pharmacol 1997;97:243-62.
142. Macklin KD, Maus AD, Pereira EF, Albuquerque EX, Conti-Fine BM. Human vascular endothelial cells express functional nicotinic acetylcholine receptors. J Pharmacol Exp Ther 1998;287:435-9.
143. Maus AD, Pereira EF, Karachunski PI, et al. Human and rodent bronchial epithelial cells express functional nicotinic acetylcholine receptors. Mol Pharmacol 1998;54:779-88. doi:10.1124/mol.54.5.779
144. Conti-Fine BM, Navaneetham D, Lei S, Maus AD. Neuronal nicotinic receptors in non-neuronal cells: new mediators of tobacco toxicity?Eur J Pharmacol 2000;393:279-94. doi:10.1016/S0014-2999(00)00036-4
145. Maouche K, Medjber K, Zahm JM, et al. Contribution of α7 nicotinic receptor to airway epithelium dysfunction under nicotine exposure. Proc Natl Acad Sci U S A 2013;110:4099-104. doi:10.1073/pnas.1216939110
146. Ahmad S, Zafar I, Mariappan N, et al. Acute pulmonary effects of aerosolized nicotine. Am J Physiol Lung Cell Mol Physiol 2019;316:L94-104. doi:10.1152/ajplung.00564.2017
147. Armstrong LW, Rom WN, Martiniuk FT, Hart D, Jagirdar J, Galdston M. Nicotine enhances expression of the neutrophil elastase gene and protein in a human myeloblast/promyelocyte cell line. Am J Respir Crit Care Med 1996;154:1520-4. doi:10.1164/ajrccm.154.5.8912774
148. Gomes JP, Watad A, Shoenfeld Y. Nicotine and autoimmunity: The lotus' flower in tobacco. Pharmacol Res 2018;128:101-9. doi:10.1016/j.phrs.2017.10.005
149. Egleton RD, Brown KC, Dasgupta P. Nicotinic acetylcholine receptors in cancer: multiple roles in proliferation and inhibition of apoptosis. Trends Pharmacol Sci 2008;29:151-8. doi:10.1016/j. tips.2007.12.006
150. Caporaso N, Gu F, Chatterjee N, et al. Genome-wide and candidate gene association study of cigarette smoking behaviors. PLoS One 2009;4:e4653. doi:10.1371/journal.pone.0004653
151. Hung RJ, McKay JD, Gaborieau V, et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 2008;452:633-7. doi:10.1038/nature06885
152. Saccone NL, Wang JC, Breslau N, et al. The CHRNA5-CHRNA3-CHRNB4 nicotinic receptor subunit gene cluster affects risk for nicotine dependence in African-Americans and in European-Americans. Cancer Res 2009;69:6848-56. doi:10.1158/0008-5472.CAN-09-0786
153. Spitz MR, Amos CI, Dong Q, Lin J, Wu X. The CHRNA5-A3 region on chromosome 15q24-25.1 is a risk factor both for nicotine dependence and for lung cancer. J Natl Cancer Inst 2008;100:1552-6. doi:10.1093/jnci/djn363
154. Lam DC, Girard L, Ramirez R, et al. Expression of nicotinic acetylcholine receptor subunit genes in non-small-cell lung cancer reveals differences between smokers and nonsmokers. Cancer Res 2007;67:4638-47. doi:10.1158/0008-5472.CAN-06-4628
155. Paleari L, Catassi A, Ciarlo M, et al. Role of alpha7-nicotinic acetylcholine receptor in human non-small cell lung cancer proliferation. Cell Prolif 2008;41:936-59. doi:10.1111/j.1365-2184.2008.00566.x
156. Babic M, Schuchardt M, Tolle M, van der Giet M. In times of tobaccofree nicotine consumption: The influence of nicotine on vascular calcification. Eur J Clin Invest 2019;49:e13077. doi:10.1111/eci.13077
157. Chaumont M, de Becker B, Zaher W, et al. Differential Effects of E-Cigarette on Microvascular Endothelial Function, Arterial Stiffness and Oxidative Stress: A Randomized Crossover Trial. Sci Rep 2018;8:10378. doi:10.1038/s41598-018-28723-0
158. Klager S, Vallarino J, MacNaughton P, Christiani DC, Lu Q, Allen JG. Flavoring Chemicals and Aldehydes in E-Cigarette Emissions. Environ Sci Technol 2017;51:10806-13. doi:10.1021/acs.est.7b02205
159. Holden VK, Hines SE. Update on flavoring-induced lung disease. Curr Opin Pulm Med 2016;22:158-64. doi:10.1097/MCP.0000000000000250
160. Gerloff J, Sundar IK, Freter R, et al. Inflammatory Response and Barrier Dysfunction by Different e-Cigarette Flavoring Chemicals Identified by Gas Chromatography-Mass Spectrometry in e-Liquids and e-Vapors on Human Lung Epithelial Cells and Fibroblasts. Appl In Vitro Toxicol 2017;3:28-40. doi:10.1089/aivt.2016.0030
161. Muthumalage T, Prinz M, Ansah KO, Gerloff J, Sundar IK, Rahman I. Inflammatory and Oxidative Responses Induced by Exposure to Commonly Used e-Cigarette Flavoring Chemicals and Flavored e-Liquids without Nicotine. Front Physiol 2018;8:1130. doi:10.3389/fphys.2017.01130
162. Behar RZ, Luo W, Lin SC, et al. Distribution, quantification and toxicity of cinnamaldehyde in electronic cigarette refill fluids and aerosols. Tob Control 2016;25(Suppl 2):ii94-102. doi:10.1136/tobaccocontrol-2016-053224
163. Park HR, O'Sullivan M, Vallarino J, et al. Transcriptomic response of primary human airway epithelial cells to flavoring chemicals in electronic cigarettes. Sci Rep 2019;9:1400. doi:10.1038/s41598-018-37913-9
164. Allen JG, Flanigan SS, LeBlanc M, et al. Flavoring Chemicals in E-Cigarettes: Diacetyl, 2,3-Pentanedione, and Acetoin in a Sample of 51 Products, Including Fruit-, Candy-, and Cocktail-Flavored E-Cigarettes. Environ Health Perspect 2016;124:733-9. doi:10.1289/ehp.1510185
165. Erythropel HC, Jabba SV, DeWinter TM, et al. Formation of flavorant-propylene Glycol Adducts With Novel Toxicological Properties in Chemically Unstable E-Cigarette Liquids. Nicotine Tob Res 2019;21:1248-58. doi:10.1093/ntr/nty192
166. Jensen RP, Luo W, Pankow JF, Strongin RM, Peyton DH. Hidden formaldehyde in e-cigarette aerosols. N Engl J Med 2015;372:392-4. doi:10.1056/NEJMc1413069
167. Salamanca JC, Meehan-Atrash J, Vreeke S, Escobedo JO, Peyton DH, Strongin RM. E-cigarettes can emit formaldehyde at high levels under conditions that have been reported to be non-averse to users. Sci Rep 2018;8:7559. doi:10.1038/s41598-018-25907-6
168. Samburova V, Bhattarai C, Strickland M, et al. Aldehydes in Exhaled Breath during E-Cigarette Vaping: Pilot Study Results. Toxics 2018;6:E46. doi:10.3390/toxics6030046
169. Sleiman M, Logue JM, Montesinos VN, et al. Emissions from Electronic Cigarettes: Key Parameters Affecting the Release of Harmful Chemicals. Environ Sci Technol 2016;50:9644-51. doi:10.1021/acs. est.6b01741
170. Bein K, Leikauf GD. Acrolein - a pulmonary hazard. Mol Nutr Food Res 2011;55:1342-60. doi:10.1002/mnfr.201100279
171. Haussmann HJ. Use of hazard indices for a theoretical evaluation of cigarette smoke composition. Chem Res Toxicol 2012;25:794-810. doi:10.1021/tx200536w
172. Kalkhoran S, Glantz SA. Modeling the Health Effects of Expanding e-Cigarette Sales in the United States and United Kingdom: A Monte Carlo Analysis. JAMA Intern Med 2015;175:1671-80. doi:10.1001/jamainternmed.2015.4209
173. Warner KE, Mendez D. E-cigarettes: Comparing the Possible Risks of Increasing Smoking Initiation with the Potential Benefits of Increasing Smoking Cessation. Nicotine Tob Res 2019;21:41-7. doi:10.1093/ntr/nty062
174. Larcombe AN. Early-life exposure to electronic cigarettes: cause for concern. Lancet Respir Med 2019;S2213-2600(19)30189-4. doi:10.1016/S2213-2600(19)30189-4
175. Visser WF, Klerx WN, Cremers HWJM, Ramlal R, Schwillens PL, Talhout R. The Health Risks of Electronic Cigarette Use to Bystanders. Int J Environ Res Public Health 2019;16:E1525. doi:10.3390/ijerph16091525
176. Gentzke AS, Creamer M, Cullen KA, et al. Vital Signs: Tobacco Product Use Among Middle and High School Students - United States, 2011-2018. MMWR Morb Mortal Wkly Rep 2019;68:157-64. doi:10.15585/mmwr.mm6806e1
177. Kulik MC, Lisha NE, Glantz SA. E-cigarettes Associated With Depressed Smoking Cessation: A Cross-sectional Study of 28 European Union Countries. Am J Prev Med 2018;54:603-9. doi:10.1016/j.amepre.2017.12.017
178. Kalkhoran S, Glantz SA. E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and metaanalysis. Lancet Respir Med 2016;4:116-28. doi:10.1016/S2213-2600(15)00521-4
179. Glantz SA, Bareham DW. E-Cigarettes: Use, Effects on Smoking, Risks, and Policy Implications. Annu Rev Public Health 2018;39:215-35. doi:10.1146/annurev-publhealth-040617-013757
180. Bullen C, Howe C, Laugesen M, et al. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet 2013;382:1629-37. doi:10.1016/S0140-6736(13)61842-5
181. Caponnetto P, Campagna D, Cibella F, et al. EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One 2013;8:e66317. doi:10.1371/journal.pone.0066317
182. Borrelli B, O'Connor GT. E-Cigarettes to Assist with Smoking Cessation. N Engl J Med 2019;380:678-9. doi:10.1056/NEJMe1816406
183. McNeill A, Brose L, Calder R, et al. E-Cigarettes: An Evidence Update. A Report Commissioned by Public Health England. Public Health England, 2015.
184. Ferkol TW, Farber HJ, La Grutta S, et al, Forum of International Respiratory Societies. Electronic cigarette use in youths: a position statement of the Forum of International Respiratory Societies. Eur Respir J 2018;51:1800278. doi:10.1183/13993003.00278-2018
185. Livingston CJ, Freeman RJ, Costales VC, et al. Electronic Nicotine Delivery Systems or E-cigarettes: American College of Preventive Medicine's Practice Statement. Am J Prev Med 2019;56:167-78. doi:10.1016/j.amepre.2018.09.010
186. Douglas CE, Henson R, Drope J, Wender RC. The American Cancer Society public health statement on eliminating combustible tobacco use in the United States. CA Cancer J Clin 2018;68:240-5. doi:10.3322/caac.21455
187. Royal College of Physicians. Nicotine without smoke: Tobacco harm reduction. 2016. https://www.rcplondon.ac.uk/projects/outputs/nicotine-without-smoke-tobacco-harm-reduction-0.
188. Leone FT, Carlsen KH, Chooljian D, et al. Recommendations for the Appropriate Structure, Communication, and Investigation of Tobacco Harm Reduction Claims. An Official American Thoracic Society Policy Statement. Am J Respir Crit Care Med 2018;198:e90-105. doi:10.1164/rccm.201808-1443ST
189. European Public Health Association. Facts and fiction on e-cigs. 2018. https://eupha.org/repository/advocacy/EUPHA-facts-and-fiction-on-e-cigs.pdf.
190. Bals R, Boyd J, Esposito S, et al. Electronic cigarettes: a task force report from the European Respiratory Society. Eur Respir J 2019;53:1801151. doi:10.1183/13993003.01151-2018
191. Cummings KM, Morris PB, Benowitz NL. Another Article About E-Cigarettes: Why Should I Care?J Am Heart Assoc 2018;7:e009944. doi:10.1161/JAHA.118.009944
192. Chadi N, Hadland SE, Harris SK. Understanding the implications of the "vaping epidemic" among adolescents and young adults: A call for action. Subst Abus 2019;40:7-10. doi:10.1080/08897077.2019.1 580241
193. Cooper EC, Hoyle PC. Guidance for Industry. 1989. https://www.fda. gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM079262.pdf.